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Abstract
Background: A preliminary study was undertaken in a community of Cyprus where low-level arsenic (As)
concentrations were recently detected in the groundwater that was chronically used to satisfy potable needs of the
community. The main objective of the study was to assess the degree of association between orally-ingested As
and self-reported type-2 diabetes mellitus (DM) in 317 adult (≥18 years old) volunteers.
Methods: Cumulative lifetime As exposure (CLAEX) (mg As) was calculated using the median As concentrations in
water, individual reported daily water consumption rates, and lifetime exposure duration. Logistic regression models
were used to model the probability of self-reported DM and calculate odds ratios (OR) in univariate and multivariate
models.
Results: Significantly higher (p<0.02) CLAEX values were reported for the diabetics (median=999 mg As) versus
non-diabetics (median=573 mg As), suggesting that As exposure could perhaps be related to the prevalence of
DM in the study area, which was 6.6%. The OR for DM, comparing participants in the 80
th versus the 20
th
percentiles of low-level As CLAEX index values, was 5.0 (1.03, 24.17), but after adjusting for age, sex, smoking,
education, and fish consumption, the As exposure effect on DM was not significant.
Conclusions: Further research is needed to improve As exposure assessment for the entire Cypriot population
while assessing the exact relationship between low-level As exposure and DM.
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Background
Arsenic (As) is a known Group A human carcinogen that
has been associated with carcinogenic and non-carcinogenic
effects in numerous epidemiologic studies around the
world [1-8]. Arsenic carcinogenicity to living organisms,
including humans, has been well established [3]. During
the last decade, a considerable shift has been directed
towards the study of non-carcinogenic effects of As,
such as dermal effects (hyperpigmentation and keratosis),
adverse pregnancy outcomes, hypertension, peripheral
vascular disease, cardiovascular diseases, respiratory dis-
eases (asthma), immune response, and type-2 diabetes
mellitus (DM) [1-8]. Even though the dose response
relationships for these various non-carcinogenic end
points seem to be well-resolved for relatively high As
exposures, i.e., > 100 μgL
-1, the shape and magnitude
of the dose–response curve for low-level As exposures
(>10 – 100 μgL
-1) is unclear. This is also the case for
DM, where low level As effects on the prevalence of DM
have yet to be fully elucidated.
Human physiologic abnormalities associated with insulin
resistance or the inability to produce enough insulin, an
essential hormone used to regulate blood glucose levels
and maintain cell metabolism, are reaching epidemic
dimensions, worldwide. Type-2 diabetes mellitus is pre-
dicted to affect a total of 366 million people by 2030,
rising from a worldwide estimate of 171 million people in
2000 [9]. Known risk factors for DM include: obesity,
older age, physical inactivity, family history, and genetic
polymorphisms [10]. Environmental toxicants, such as
As, have been implicated in the etiology of DM in epide-
miologic and animal studies [11,12]. Relatively high
exposure scenarios (> 100 μgL
-1) have been studied in
epidemiologic studies [5,13,14]. whereas only a few have
focused on low-level As exposures (< 100 μgL
-1) [15,16].
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between low level As exposure and DM led us to investi-
gate this further, by selecting a specific area of Cyprus
that had been chronically exposed to As in groundwater
used for potable purposes. During the last two decades,
DM has been a major determinant of the overall burden
of disease in Cyprus [17]. Recent data from the only
available epidemiologic study in Cyprus showed that
6.5% of the adult population (between 20–80 years old)
had DM, while there was another estimated 3.8% of the
adult population who remained undiagnosed [17].
The main objective of this study was to assess the
degree of association between orally-ingested As and
self-reported DM in a specific area of Cyprus. A detailed
questionnaire was completed by 414 residents of the As-
affected community in Cyprus, and data on demographic
characteristics, water use habits, and medical history
were also collected.
Methods
Study location and characteristics
The small community of Mammari (~ 1600 residents)
(CENSUS data) in the Nicosia prefecture of Cyprus was
chosen for this study, because of recently documented
groundwater pollution with As that was used to satisfy
the area’s potable needs. During the summer of 2009,
regulatory agencies of the Cypriot government detected
As concentrations in samples of the groundwater and
home tap water in the Mammari area, exceeding the
maximum contaminant level value of As in drinking-
water (10 μgL
-1). Uncertainties associated with the
duration of exposure, magnitude of As intake, and the
possible health effects largely prevailed. A wide range of
As concentrations in the region’s groundwater has been
observed (< 10 – 70 μgL
-1 As), and a value of ~40 μgL
-1
was chosen for the calculation of an individual’sd a i l y
As intake.
This study was undertaken in parallel with that of
a national scientific committee on As health effects
organized by the Cypriot Ministry of Health. Our study’s
collection of questionnaires and data protection was
accompanied by signed informed consent from each par-
ticipant and all participants were able to ask questions
about the study. The signed informed consent mentioned
that participants agreed to disclose personal data for the
study analyses, while full review was not required, since no
biological tissue sampling was done and no external
funding was involved. Our study approach followed the
same guidelines of the bioethics protocol used by Harvard
School of Public Health to conduct the Kuwait Pilot
Medical Monitoring Study (D. Christiani, Harvard School
of Public Health, personal communication). The As-affected
area’s local administrative council (Mammari, Cyprus)
approved the study and it was held responsible for
distributing questionnaires to all of their residents. The
questionnaire was based on the original questionnaire
used in the Kuwait Pilot Medical Monitoring Study
and it was modified to account for the specific lifestyle
habits of Cyprus. The study questionnaire focused on
individual information, such as demographics, water use
habits, and medical history. An informed consent was
signed by all volunteers prior to completing the question-
naire. The questionnaire was self-administered and was
completed by 414 volunteers in the community.
Study subjects
Of the 414 volunteers, 317 were finally included in our
analyses. Questionnaires were excluded from volunteers
who were less than 18 years of age (N=87) because this
study was focused on the adult population. In addition,
ten individuals with unrealistically high reported daily
water consumption (> 5 Lday
-1) were similarly excluded.
DM status for the 317 adult volunteers in our sample
was based on self-reporting as a response to the question
‘what chronic disease(s) have you been diagnosed with so
far by your physician’.
Arsenic exposure assessment
We utilized data from the questionnaires to compute a
cumulative lifetime As exposure (CLAEX) index (mg As)
for each participant. The CLAEX index incorporated
individual information on drinking-water daily consump-
tion rates and duration of exposure to As in this
small community, assuming a lifetime exposure scenario.
Exposure duration was set equal to the number of years
an individual spent in the As-affected area, knowing
that the As-contaminated tap water was the main or
exclusive source of drinking-water for>98% of residents
participating in our study. Cypriot population data were
obtained from the 2001 CENSUS report of the Statistical
Service, Ministry of Finance, Cyprus. The CLAEX
index for each individual participant was calculated as
(estimated median As concentration in contaminated
water, μgL
-1)×(daily amount of contaminated water
consumed from that well, L day
-1)×(duration of expos-
ure to contaminated water, days), assuming all years
living in the As-affected area and consuming water from
the well had same consumption rates and same median
40 μgA sL
-1 and with the rest of the years (either
outside Mammari or not using the well) assumed to be
exposed to a median of 1 μgA sL
-1. This index has been
similarly used in Bangladesh [18] and showed no signifi-
cant (p>0.05) difference in the prediction of mortality
rates between this cumulative As index and that based
on a daily As dose as calculated from drinking-water As
concentration data. Water consumption rates were
individually calculated based on responses about how
many glasses of water were daily consumed (based on
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~250 mL water).
Statistical analysis
CLAEX indices were right-skewed, and hence were
logarithmically transformed for the analyses. Arsenic
exposure was presented as median with the correspond-
ing interquartile range (IQR) and in order to compare
As exposure between different groups we used t-tests
and analysis of variance on the log-transformed values.
The ratio of geometric means for the cumulative lifetime
As exposure index values comparing participants with
type II diabetes versus participants without were com-
puted using linear regression models (both unadjusted
and adjusted for age, sex, education level, and smoking
status) on the log-transformed values of As exposure.
This was done for the overall sample, but also for
subgroups defined by: age, sex, age, education level,
smoking, water use for cooking, and consumption of
fish. Logistic regression models were used to model the
probability of self-reported diabetes and calculate odds
ratios in univariate and multivariate models for several
covariates of interest, as well as 95% Wald confidence
intervals. Arsenic exposure was included in the logistic
regression models as a continuous variable but also in
terms of tertiles and quintiles of As exposure. All
statistical analyses were performed using SAS 9.1 (SAS
Institute, Inc.) and all statistical tests reported were two-
sided. Statistical significance was set at p-value <0.05.
Results
The median (interquartile, IQR) value of CLAEX for all
participants in this study was 613 (237–1305) mg As
(Table 1). Median male CLAEX indices were similar to
those of females (Table 1). Significantly different (p<0.001)
CLAEX indices were observed by age (18–40, 40–60, and
>60 years old) with the oldest group having the highest
index and the median indices being: 336, 716 and 1483 mg
As for each respective age group. Similarly, participants
with higher education had significantly (p<0.001) lower
CLAEX indices than those finishing only elementary or
high school (Table 1). Approximately 32% of the sampled
population was currently smoking, but there was no
significant difference (p>0.05) in CLAEX indices among
smokers and non-smokers. A slightly lower % (25%) of
current adult (>20 years old) smokers for the whole
Cypriot population was recently reported by the Statistical
Service of Cyprus [19]. Those participants using the
groundwater from the As-contaminated area for cooking
(93%) had significantly higher CLAEX indices than those
who did not use it (p=0.03) (Table 1). Up to 87% of our
sample in the As-affected region was consuming potable
water up to 2.5 L capita
-1 day
-1, while the rest 13% con-
sumed water between 2.5 and 4 L capita
-1 day
-1 with a
median value of 2.0 L capita
-1 day
-1 (data not shown). Up
to 92% of our sample was exposed to As in potable water
for a period up to 60 years, with a median exposure
duration value of 16 years (data not shown).
Self-reported DM prevalence in our sample from this
As-affected region of Cyprus was 6.6%, which is similar
to the officially reported DM prevalence for Cyprus of
6.5% by Loizou et al. [17]. Significantly higher (p=0.02)
CLAEX index values were observed for the diabetics
(999 mg As) versus the non-diabetics (573 mg As)
(Table 1). Reported fish consumption was not associated
with CLAEX values as calculated from drinking water in
this study. A multi source human As exposure assess-
ment from both seafood and fish, rice and drinking-
water in Cyprus suggested that seafood and fish had little
influence to the overall lifetime average daily As dose
[20], corroborating the fish and seafood consumption
results from this study.
Multivariate models adjusted for age, sex, and smoking
status showed that participants with DM (though not
statistically significant) had 22% higher CLAEX index
values (95% CI 0.74, 1.99) than those participants
without (Table 2). Subgroup analyses on the adjusted
(age, sex and smoking status) ratio of geometric means
showed that the association between As exposure and
DM cases was lower in those participants with lower
educational level, who were males, older, smokers, not
using water to cook, and consumed fish between 1–3
times per week (Table 2).
Age, smoking, and As exposure (log-transformed
CLAEX) were significant predictors of increased odds of
DM in univariate models (Table 3). Arsenic exposure
was associated with an almost 80% increase in the odds
of DM (OR=1.78; 95% CI: 1.08, 2.93). Sex and education
were not significant predictors of increased odds of DM.
The unadjusted OR for DM comparing participants in
the 80
th vs. the 20
th percentiles of total As exposure
(CLAEX index) was 5.00 (95% CI: 1.03, 24.17).
In multivariate models adjusted for age, sex, and smok-
ing, As exposure effects on DM categorized in quintiles
was no longer statistically significant (Table 3).
Discussion
This is the first study evaluating the relationship between
human As exposures (via the consumption of contami-
nated groundwater) and the prevalence of DM in an As-
impacted region of Cyprus. We conducted this study in
a specific rural area of Nicosia, Cyprus where As con-
tamination of groundwater was discovered in June 2009.
In the absence of As human biological markers of expos-
ure, we used a CLAEX As exposure index, which has
also been used in large prospective cohort studies in As
endemic areas of the world (Bangladesh) [18]. We found
that increasing cumulative lifetime exposure to As, as
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increased odds of DM in unadjusted models. However,
given the relatively small sample size of this study, the
confidence intervals were wide and, after adjustment for
several important covariates such as age, were no longer
statistically significant.
Nonetheless, this study provides important information
for human health risk assessment in the region. Epide-
miologic data on diabetes in Cyprus are scarce and
prevalence estimates for adults>20 years old range from
5.1% to 10.3%. The EU-wide average prevalence of
DM is around 7.5% [21] while the U.S. prevalence of DM
is 7.7% according to data from the National Health
and Nutrition Examination Study (NHANES) [15]. Sex-
specific population age distribution patterns were quite
similar between the study area and that of the whole
Cyprus (data not shown). The mean DM prevalence of
the diagnosed cases in the study area (6.6%) was similar
to that for Cyprus as a whole (6.5%) [17], suggesting that
our study population is not different in this respect than
the Cypriot population in general.
Low-level As exposure studies focusing on the risk of
chronic diseases, such as DM, are limited worldwide
and, thus, a causal association between low-level As
exposure and the prevalence of DM has yet to be
confirmed. Recent mechanistic data imply that low-level
As exposures provoke a cellular adaptive oxidative
stress response involved in glucose-stimulating insulin
secretion, and eventually disturbed β-cell function [22].
However, it is also true that having a chronic disease,
such as DM, may alter As metabolism and thus lead to
higher exposures among diseased individuals.
According to recent data obtained from regulatory agen-
cies in Cyprus, As concentrations in groundwater in this
study were typically<50 μgL
-1. The lack of adequate As
exposure assessment estimates due to absence of a system-
atic and network-wide well-water As concentrations led us
to use the median value of 40 μgL
-1, which may
Table 1 Median values and their interquartile range values of the cumulative lifetime arsenic exposure indices (CLAEX)
calculated for the As-affected study area of Cyprus
N (%) Median CLAEX (IQR) (mg As) p-value
Total # Participants 317 613.07 (236.9, 1304.9)
Sex 0.59
Female 167 (53) 634.62 (231.2, 1337.4)
Male 150 (47) 604.67 (259.1, 1271.1)
Age Group <.0001
18-40 121 (38) 335.85 (136.6, 635.5)
40-60 123 (39) 715.89 (259.1, 1314.9)
60 + 73 (23) 1482.92 (847.0, 1957.7)
Education <.0001
Elementary 85 (27) 1337.36 (697.6, 1838.1)
High School 139 (44) 568.88 (275.7, 1183.4)
Undergraduate 71 (22) 335.85 (138.7, 803.5)
Post-graduate 22 (7) 349.82 (96.4, 550.6)
Smoking 0.99
No 217 (68) 635.54 (250.9, 1303.9)
Yes 100 (32) 593.99 (196.0, 1405.3)
Use of Water for Cooking 0.03
No 20 (7) 241.98 (85.3, 1019.0)
Yes 296 (93) 646.13 (253.9, 1321.2)
Diabetes 0.02
No 296 (93) 573.31 (222.7, 1277.0)
Yes 21 (7) 998.59 (543.3, 1838.1)
Fish Consumption 0.64
No 79 (25) 731.23 (159.4, 1285.7)
1-3/week 224 (71) 615.45 (251.8, 1322.6)
More than 1–3/week 14 (4) 489.30 (221.3, 1227.2)
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However, our post sensitivity analysis using a median value
of 20 μgL
-1 did not significantly (p>0.05) change the uni-
variate and multivariate-based OR of DM and trends
observed in this study (data not shown). Thus, this study
provides adequate information on the association between
low-levels As exposure and risk of developing DM. The
collection of individual data on daily drinking water con-
sumption as well as the exposure duration and adjustment
of several DM risk factors strengthened the results of this
study.
Study limitations
Despite these important aspects of this study, there were
several limitations. In particular, the small sample size
(317 participants) limited the statistical power to observe
an effect of low As exposure on DM. Several important
risk factors for DM, such as family history of DM and
BMI, were not available, thus limiting our ability to
address relative contributions of these factors to the
observed OR of DM and to better estimate the relative
contribution of As exposure to DM after adjusting for
these factors. Epidemiologic studies on the association of
low-level (< 100 μgA sL
-1) As exposure and the risk of
developing lung and bladder cancer were limited in their
ability to detect the predicted estimates of excess risk
because of sample size and less than lifetime exposure
[23]. Additional studies with larger sample sizes are
needed to lower the magnitude of uncertainty in the
conclusions.
Another limitation of this study was the absence of
biomarker As data, such as toenails, elucidating historic
As exposure patterns. Toenail As data provides historic
evidence of As exposure via both drinking water and
food diet exposure pathways [24-27]. However, we used
a cumulative exposure index as a surrogate of lifetime
As exposure to drinking water that has previously
been used in large epidemiologic studies. Recent studies
have observed a highly significant (p<0.001) positive
correlation between toenail As concentrations and As
concentrations in drinking water [26,27]. From a study
conducted by the Cypriot Ministry of Health that we
Table 2 Ratios of geometric means for the cumulative lifetime arsenic exposure index values comparing participants
with type II diabetes versus participants without
Unadjusted Ratio of Geometric Means (95% CI) Adjusted* Ratio of Geometric Means (95% CI)
Overall 1.93 (1.11, 3.39) 1.22 (0.74, 1.99)
Sex
Female 1.99 (0.77, 5.16) 1.57 (0.70, 3.46)
Male 1.88 (0.96, 3.67) 1.11 (0.59, 2.08)
Age group
18-40 years 1.65 (0.28, 9.58) 1.48 (0.25, 8.58)
40-60 years 1.20 (0.51, 2.80) 1.19 (0.50, 2.77)
>60 years 1.13 (0.70, 1.79) 1.26 (0.79, 2.01)
Education
Elementary 1.16 (0.53, 2.53) 1.35 (0.73, 2.48)
High School 1.84 (0.83, 4.14) 1.08 (0.47, 2.51)
Undergraduate 2.36 (0.55, 10.28) 1.51 (0.37, 6.11)
Post-graduate 4.81 (0.25, 93.69) 1.95 (0.11, 34.81)
Smoking status
No 1.63 (0.73, 3.63) 1.25 (0.62, 2.53)
Yes 2.34 (1.05, 5.21) 1.20 (0.58, 2.44)
Using water to cook
No 2.27 (0.25, 20.70) 0.73 (0.08, 6.36)
Yes 2.05 (1.14, 3.71) 1.36 (0.80, 2.29)
Consumption of Fish
No 2.14 (0.62, 7.32) 1.43 (0.45, 4.62)




*Adjusted for age, sex, education and smoking status.
** Inadequate available subgroup sample size to run the model.
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small case–control group of people (N=65 for cases and
similar number for the control group) comparing those
in the As-affected area with those in the unaffected area.
Toenail As concentrations were significantly higher
(p<0.001) in the As-affected area compared to those in
an As-unaffected area of Cyprus (unpublished).
Dietary As intake, via the consumption of seafood, may
also contribute to the overall As daily dose [27]. In Bangla-
desh, at drinking water As concentrations>50 μgA sL
-1,
Table 3 Univariate and multivariate models predicting the odds ratios of developing diabetes mellitus among the
participants of the study area in Cyprus
Univariate Models OR (95% CI) p-value
Sex – Males vs. Females 1.876 (0.75, 4.66) 0.18
Age (year) 1.047 (1.02, 1.08) 0.001
Smoke – Yes vs. No 2.563 (1.05, 6.25) 0.04
Log arsenic exposure (mg) 1.777 (1.08, 2.92) 0.02
Education
High School vs. Elementary 0.672 (0.25, 1.81) 0.43
Undergraduate vs. Elementary 0.431 (0.11, 1.69) 0.23
Postgraduate vs. Elementary 0.481 (0.06, 4.07) 0.50
Tertiles of arsenic exposure
Second vs. First 4.781 (1.01, 22.69) 0.05
Third vs. First 5.368 (1.15, 25.13) 0.03
Quintiles of arsenic exposure
Second vs. First 0.968 (0.13, 7.09) 0.97
Third vs. First 2.632 (0.49, 14.11) 0.26
Fourth vs. First 1.500 (0.24, 9.30) 0.66
Fifth vs. First 5.000 (1.03, 24.17) 0.04
Multivariate Models OR (95% CI) p-value
Model 1
Age (year) 1.036 (1.00, 1.07) 0.04
Males vs. Females 1.280 (0.43, 3.84) 0.66
Smoke – Yes vs. No 2.034 (0.69, 5.99) 0.20
Log arsenic exposure (mg) 1.287 (0.74, 2.25) 0.38
Model 2
Age (year) 1.041 (1.00, 1.08) 0.02
Males vs. Females 1.268 (0.42, 3.81) 0.67
Smoke – Yes vs. No 2.000 (0.68, 5.91) 0.21
Tertiles of arsenic exposure
Second vs. First 3.493 (0.70, 17.33) 0.13
Third vs. First 2.287 (0.41, 12.66) 0.34
Model 3
Age (year) 1.038 (1.00, 1.08) 0.03
Males vs. Females 1.425 (0.47, 4.29) 0.53
Smoke – Yes vs. No 1.867 (0.63, 5.51) 0.26
Quintiles of arsenic exposure
Second vs. First 0.717 (0.09, 5.56) 0.75
Third vs. First 1.791 (0.31, 10.26) 0.51
Fourth vs. First 0.774 (0.109, 5.516) 0.80
Fifth vs. First 1.857 (0.298, 11.592) 0.51
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humans, whereas at As concentrations<50 μgA sL
-1,t h e
dominant route of exposure was dietary [26,27]. Food items
that are cooked in As-contaminated water may absorb As
at the cooking temperature and, thus, enter the food chain
[26,27]. Epidemiologic studies in the U.S. based on
NHANES data showed that controlling for nontoxic forms
of As (arsenobetaine in seafood) aided in better illustrating
the inorganic As effect on human health [15]. The U.S.
EPA defines a reference dose level for As of 0.3 μgA s
kg
-1 day
-1 for a 70 kg adult, but, interestingly, increased
risk for DM was shown for doses less than this reference
dose [15]. Mean daily dietary inorganic As intake (DII) for
Cypriots (from fish/seafood, rice and water) with average
5 μgA sL




[20]. Seafood and fish consumption was not a significant
predictor of DM, paralleling results from a recent prob-
abilistic exposure assessment conducted for the Cypriot
population [20]. Results from that study showed that fish,
seafood and rice consumption in Cyprus contributed
<25% of DII, while drinking water contributed >75% of
DII [20], despite the documented high consumption rates
of fish/seafood and rice in Cyprus. It, thus, follows that fo-
cusing on drinking-water, instead of dietary items, is ad-
equate in estimating overall inorganic As exposure. The
DII global estimates typically use a median value of 2.0 L
capita
-1 day
-1 water consumption rate estimates, which is
similar to that estimated in our As-affected study area.
In summary, well-designed epidemiologic studies for
low-level As exposure scenarios, such as that encoun-
tered in Cyprus, are lacking. Small communities (< 2000
residents), such as the As-affected area of Cyprus, that
typically rely on groundwater to satisfy their potable
needs are widespread throughout the globe. These com-
munities may lack centralized drinking water treatment
facilities that could provide them with contaminant-free
drinking water. This study highlights the importance of
conducting detailed As exposure assessment and risk
calculations in such communities. The spatial and tem-
poral variability of groundwater As contamination in
Cyprus is currently unknown and regulatory agencies of
Cyprus are interested in further looking into it. Future
research is envisioned in accurately measuring the uncer-
tainty of As external and internal exposure measurements
for different areas of Cyprus, while attempting to quantify
the relationship between As exposures and DM by recruit-
ing a larger volunteer size. The completion of a human
health risk assessment based on the annual total social
costs for alternative As intervention measures is expected
in the near future.
Conclusions
This preliminary assessment of environmental risk factors,
such as As, on the etiology of DM will generate guidelines
and recommendations for similarly As-affected rural
areas in Cyprus and in the Eastern Mediterranean region.
Arsenic-impacted communities are in need of exposure-,
and epidemiologic-based information to identify proper
remediation plans and ways to minimize As-related mor-
bidity. Diabetes prevention programs have mostly focused
on medication and lifestyle modification, but the role of
environmental exposures must also be considered.
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